PHILADELPHIA — A three-pronged immunotherapy approach nearly doubles five-year survival among patients with rare leukemic form of cutaneous T-cell lymphoma, reports a new study by dermatologists from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania.
Perelman School of Medicine
Zachary Meisel of the Perelman School of Medicine co-authors an article on secret “doctor shopping.”
PHILADELPHIA — A pandemic of ailments called the "allergic march" -- the gradual acquisition of overlapping allergic diseases that commonly begins in early childhood -- has frustrated both parents and physicians. For the last three decades, an explosion of eczema, food allergies, hay fever, and asthma have afflicted children in the United States, the European Union, and many other countries.
Arthur Caplan of the Perelman School of Medicine comments on and questions the “existence of the Latino health paradox.”
Anna Marie Chang is quoted about her research, led by Judd Hollander of the Perelman School of Medicine.
Ezekiel Emanuel is Penn’s newest Penn Integrates Knowledge Professor, in the Perelman School of Medicine and the Wharton School.
Arthur Caplan of the Perelman School of Medicine comments on abortions in India that skew the boy-girl ratio of the country.
(PHILADELPHIA) -- In a cancer treatment breakthrough 20 years in the making, researchers from the University of Pennsylvania's Abramson Cancer Center and Perelman School of Medicine have shown sustained remissions of up to a year among a small group of advanced chronic lymphocytic leukemia (CLL) patients treated with genetically engineered versions of their own T cells.